Andere talen Harvard Bioscience, Inc.

Aandelen

HBIO

US4169061052

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,56 ^USD	-3,52%		-10,33%	-33,46%

09/04	Harvard Bioscience vermindert personeelsbestand	MT
09/04	Harvard Bioscience, Inc. Kondigt maatregelen aan om de operationele efficiëntie te verbeteren en de lopende investeringen in groei te ondersteunen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Harvard Bioscience Reducing Headcount	09/04
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth	09/04
Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth	09/04
Harvard Bioscience, Inc. Enters into A Third Amendment to the Credit Agreement	03/04
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference	11/03
Harvard Bioscience: Q4 Earnings Snapshot	07/03
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 Revenue $28.2M	07/03
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04	07/03
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results	07/03
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results	07/03
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2024	07/03
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	07/03
North American Morning Briefing : Powell Still in -2-	07/03
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting	06/03
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications At Society of Toxicology Meeting	06/03
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET	27/02
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET	27/02
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023	20/11
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023	20/11
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023	09/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Harvard Bioscience, Inc.

Aandelen

HBIO

US4169061052

Andere talen

Filters